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KEY INSIGHTS 
1. Numerous diverse compliance areas affect the 
supply chain in a pharmaceutical company. 
2. Recording and analyzing non-compliance 
incidents consistently can be an effective tool to 
measure compliance performance. 
3. Generating a centralized database on 
compliance requirements and incidents 
increases visibility of compliance and it is 
expected to enable improved compliance. 
 
Introduction 
For any organization, compliance is about ensuring 
that business processes, operations and practices 
are in accordance with the prescribed set of norms. 
Pharmaceutical companies are subject to stringent 
compliance requirements set by governments and 
international regulatory bodies. Meeting these 
compliance requirements is a tremendous challenge 
due to the dynamic and diverse nature of the 
regulatory landscape and the complexity of the 
supply chains. Every day, within the global supply 
chain, thousands of raw materials sourced from 
suppliers around the world are brought to global 
manufacturing sites. The finished products are then 
distributed to various markets across the globe. 
Hence, several players interact in the supply chain 
to ensure compliance. Failure to ensure compliance 
can have a negative impact on any organization with 
consequences ranging from minor fines to economic 
sanctions to the complete closure of the business. 
More than 500 product recalls occurred due to non-
compliance issues in 2011 alone and the costs 
related to regulatory infractions by 8 leading US 
pharmaceutical companies from 2007-2012 were 
$7.2 billion. Companies have to continuously 
monitor the regulatory norms and ensure timely 
completion of the compliance requirements. While 
compliance management is very important, currently 
there is a lack of metrics to track the compliance 
performance of the global supply chain, i.e., there is 
no systematic approach to compliance 
measurement. [Various articles have been written 
that analyze the different areas of compliance within 
the supply chain such as temperature control, 
serialization and labeling. However, we were unable 
to find any previous work that has been done in 
integrating all the different compliance areas 
affecting the supply chain into one holistic 
measurement concept or KPI.] The problem was to 
develop a quantitative measure for compliance of 
the entire supply chain that integrates the diverse 
compliance areas. 
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In order to structure our approach, we used the 
systems engineering methodology and the basic 
supply chain processes of Plan, Source, Make, 
Deliver, Return and Enable from the Supply Chain 
Operations Reference (SCOR®) model. Apart from 
literature review, Interviews were conducted with 
subject matter experts from different departments 
within the supply chain of our sponsor company to 
understand how their function is affected by 
compliance requirements, and the characteristics 
important for a compliance metric. One key finding 
from the interviews was the need of a centralized 
database within the company to keep a record all 
compliance related incidents. 
Sources of Compliance 
It is crucial for companies to understand all the 
regulations that affect them. In order to keep track of 
the requirements, it is important to identify the 
organizations responsible for approving and 
modifying regulations, because they will be a key 
part of the compliance control process.  There are 3 
types of bodies: 
1. National Bodies: Each country has its own 
regulatory bodies that set regulations for 
compliance across the supply chain e.g., 
US-FDA, European Commission, Japanese 
Ministry of Health & Welfare. 
2. International Bodies: These organizations 
help to homogenize the different regulations 
across countries e.g., WHO, WCO and ICH 
3. Internal company sources: Most companies 
set rules to organize their own operations, 
so the company and its rules are itself a 
source of compliance regulations e.g., 
Standard Operating Procedures (SOP’s) 
Compliance Areas 
Based on the interviews with various subject 
matter experts within the supply chain of our 
sponsor company, we have identified and then 
grouped and defined the following 12 areas of 
compliance that affect the supply chain in the 
pharmaceutical industry. 
Compliance Areas 
1  Legal 
2  Ethics 
3  Safety 
4  Temperature Control 
5  Labeling 
6  Serialization 
7  Export Control 
8  Trade 
9 
Storage, Handling and 
Transport 
10  Sustainability 
11 
Electronic Data and 
Communication 
12  Security 
 
Compliance Measurement Model: Matrix of Non-
compliance 
Our model is based on gathering information about 
detected non-compliance incidents, quantifying the 
negative impact of each such incident, determining 
the department within the supply chain responsible 
for the incident and the compliance areas affected 
by it. This information is organized into a matrix of 
non-compliance incidents. In this matrix, each row 
represents a department of the company and each 
column represents a compliance area that affects 
the part of the company under the scope of the 
model. The model is based on populating each cell 
of the matrix with the sum of the value (score) of the 
negative impact of each non-compliance incident for 
each compliance area. The score in each cell of the 
matrix takes into account all the incidents detected 
by the company using all the information available 
including the internal and external audit findings. A 
representative example of the matrix with 2 
compliance areas is shown below: 
The compliance score in each cell is the summation 
of the product of the number of incidents of non-
compliance and the criticality of each such incident. 
Compliance Score =∑ ݊௜ ∗ ܥ௜௜ୀூ௜ୀ଴  , such that,  
I = set of all possible incidents 
ni = number of incidents of type i  
Ci = criticality of incident of type i  
Mapping compliance and criticality concept 
SC	Departments
Temperature	
control 
Delivery 
Planning 
Compliance	Areas 
Labelling 
1,1 1,2
2,1 2,2
3,1 3,2
4,1 4,2
Sourcing 
Storage 
Each non-compliance incident must be recorded and 
mapped to a particular area of compliance and also 
to a specific department within the part of the 
company using the system. For example, if there is a 
temperature excursion during the transportation 
process of a product from a factory to a warehouse 
the mapping of this is reflected as a count of 1 in the 
temperature control compliance area within the 
transportation department. The procedure for 
recording non-compliance incidents is important for 
the measurement concept and is such that it is 
allocates the responsibility of non-compliance to the 
appropriate department in the supply chain. 
Investigations must be conducted when the root 
cause of the incident is not clear. 
The appropriate criticality rating is given for each 
type of discrepancy that can occur within each area 
of compliance. The main drivers of the criticality are: 
financial impact, impact on people/patients safety, 
impact on reputation and whether the incident is 
detected in-house or by an external stakeholder 
(customers, suppliers, regulatory bodies and so 
forth).  Based on to the characteristics of the 
company and its perception of risk, values must be 
assigned for each impact driver. For each incident, 
these values will be assigned to the four drivers and 
will be combined to calculate the final criticality 
score. Each incident can have low, medium or high 
impact and criticality values as follows: 
IMPACT VALUE 
None 1 
Low 10 
High 100 
Also, if an incident is detected by an external agency 
(regulatory body or channel partner) it will be twice 
the criticality than if it were detected in-house. 
Hence, the criticality score for in-house will be 1 
whereas for external agency will be 2, e.g., a 
hospital reports that a product supplied has the 
wrong dosage information on the label. A non-
compliance incident has occurred and the criticality 
rating for this incident will be calculated as follows: 
IMPACT CATEGORY VALUE
A- Effect on patients High 100
B- Economic impact Medium 10
C- Impact on company’s 
reputation 
Low 10
D- Detection External 2
Criticality score: (100 x 10 x 10 x 2) = 20,000 
This flexible definition of the criticality concept allows 
for inclusion and evaluation of all types of incidents. 
Moreover it helps to deal with the great variety of 
potential incidents that the company has to face. For 
instance, the impact of each incident will change 
depending on parameters such as the product or 
products affected by the incident and the department 
where in the incident occurred. It also depends on 
the preparedness of the company to deal with 
compliance. For instance, if a company has in place 
good corrective processes, when a non-compliance 
incident occurs, it can react quickly and mitigate the 
impact of such an incident.  Hence the criticality 
rating being user defined, the user will assign a low 
criticality to such an incident. 
The criticality criteria are sensitive and should be 
defined carefully since for instance if a low criticality 
score is assigned to a high impact incident then the 
measurement model will provide a wrong picture of 
the compliance. 
Compliance KPI and Scorecard 
Compliance KPI is based on tracking all the 
incidents, assigning the criticality and feeding this 
information into our proposed measurement system 
to generate the KPI for compliance. All the incidents 
during a defined period of measurement say one 
month will be recorded. First, we analyze only the 
count of non-compliance incidents. 
  Electronic data & 
Com
m
unications 
Ethics 
Export control 
Labeling 
Legal 
Total 
Plan  0  0  0  0  1  1 
Source  0  1  0  0  0  1 
Make  0  0  0  0  0  0 
Deliver  1  0  3  1  0  5 
Total   1  1  3  1  1  7 
 
Next, we add the criticality rating and calculate the 
compliance score for the entire matrix. 
  Electronic data & 
Com
m
unications 
Ethics 
Export control 
Labeling 
Legal 
Total 
Plan  0  0  0  0  2000 2000 
Source  0  10  0  0  0  10 
Make  0  0  0  0  0  0 
Deliver  200  0  24000  20000  0  44200
Total   200  10  24000  20000  2000 46210
 According to the criticality concept defined, the 
KPIvalue measures the effect of the non-compliance 
incidents on the organization The global compliance 
KPI would be the sum of the criticality of all the 
incidents during the control period. For this case, the 
value of the KPI is: 46210. 
The higher the score the worse is the performance 
of the company. Therefore the ideal or best 
compliance score would be zero. To provide more 
meaning to this compliance KPI value, it would be 
advisable to use a range of allowable values for 
each area of compliance. The range of values for 
the KPI should be chosen carefully by each user of 
this model. For example, the company should 
decide this range depending on its own risk 
evaluation and the level of stringency desired.  
With this, we will be able to generate a scorecard 
that displays how compliant each department is 
within the supply chain and also display the 
performance of the company with respect to all the 
identified areas of compliance. The last step will be 
defining alarms in the system. For example, if the 
value of a particular compliance KPI goes outside 
the allowable range (or over the threshold limit), it 
should be color coded with Red, indicating high 
danger. Another powerful tool as shown below is a 
trend indicator that shows how the compliance score 
for an area has changed over previous time periods 
(increase, decrease or no change).  
COMPLIANCE PERFORMANCE KPI 
46,210 
 
FUNCTIONS COMPLIANCE AREAS 
Plan 2,000 (2,000) 
Electronics Data 
and 
Communication 
200 
(10) = ↑ ↓
Deliver 44,200 (3,419) Ethics 
10 
(1) ↓ ↓ ↓
Make 0 (70) Labeling 
44,000 
(20,000) ↑ ↑ =
Source 10 (1,005) Legal 
2000 
(70) = = =
 
Continuous Improvement Process 
Compliance requirements change over time, so the 
system must be flexible to adapt. The analysis of the 
database generated of non-compliance incidents is a 
tool for the company to detect areas of improvement. 
Also, the evolution over time of the compliance 
performance of each department will help to detect to 
identify problems and plan corrective or preventive 
action. As the system offers a KPI for measuring 
compliance of each department, this will help to set 
clear goals and targets for the company. 
Steps necessary for implementing the model 
To implement the proposed measurement model, the 
following tasks need to be performed: 
1. Scope definition  
2. Procedure definition –  The procedure 
defining the procedure for recording 
compliance incidents, i.e., who, where and 
how will the information be recorded. 
3. Database and Interface creation - An 
interface to help users introduce information 
should be created, ensuring consistency of 
the data by defining controls within the 
interface. 
4. Information and training- All stakeholders 
using the system should be trained 
5. Review of parameters of the system – The 
criticality criteria may need to change 
depending on the risk assessment and 
changing regulatory requirements. 
Conclusion 
The proposed methodology can be applied to a 
whole company or parts of it for compliance control 
and to serve as a central control tower. It provides a 
clear picture of how well each area of the company is 
performing and identifies areas for improvement. It 
also enables the company to monitor the effect of  
improvement actions.  
The limitations of the measurement model are that it 
does not provide a predictive tool on compliance nor 
can it predict sudden disruptions to the supply chain 
as a result of non-compliance issues. Based on 
historical performance, the tool serves as an 
indicator of areas with a higher likelihood of non-
compliance if no corrective action has been taken. 
Our results show that our model can be successfully 
applied to the supply chain to provide a quantitative 
measure for the compliance performance in each 
compliance area. The system is very flexible and can 
be modified to include new regulations and risks that 
affect the company. 
